The infertility treatment market size has grown strongly in recent years. It will grow from $1.82 billion in 2024 to $1.97 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to growing awareness and education, changing lifestyles and environmental factors, rising incidence of male infertility, government initiatives and support, shift in social perceptions.
The infertility treatment market size is expected to see strong growth in the next few years. It will grow to $2.8 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to expanding access to fertility clinics, advances in reproductive medicine, innovations in gamete and embryo culture, advancements in male contraception, focus on oocyte quality improvement. Major trends in the forecast period include technological advancements in assisted reproductive technologies (art), increasing prevalence of infertility, expanding age of parenthood, fertility preservation services, nutritional and lifestyle interventions.
The decline in the global fertility rate is a significant factor driving the growth of the infertility treatment market. The fertility rate at a specific age is defined as the number of children born alive to women of that age during the year, expressed as a percentage of the average annual population of women of that age. Globally, the fertility rate has been steadily decreasing due to various factors, including the increasing trend of late marriages and rising age-related infertility. This reduction in fertility rates has resulted in a marked increase in the demand for infertility treatment products that help determine the fertility window for both males and females. For example, in June 2022, the World Economic Forum, a Switzerland-based international non-governmental organization, reported that fertility rates have declined worldwide over the past 70 years, with a total decrease of 50% recorded in 2022. Thus, the decline in the global fertility rate is driving the demand for infertility treatment products.
The increasing demand for surrogacy is anticipated to drive the growth of the infertility treatment market in the future. Surrogacy is a reproductive arrangement in which a woman, known as the surrogate, carries and gives birth to a child for another individual or couple, referred to as the intended parents. This option is often pursued in infertility treatment when a woman or couple cannot carry a pregnancy due to medical issues, repeated pregnancy loss, or other fertility challenges. For example, in December 2022, The Australian Broadcasting Corporation, an Australia-based radio broadcasting station, reported that approximately 100 Australian women give birth to babies for other families each year through surrogacy. Therefore, the rising demand for surrogacy is fueling the growth of the infertility treatment market.
Technological innovation is a significant trend gaining traction in the infertility treatment market. Leading companies in this sector are concentrating on developing new technological solutions to enhance their market position. In July 2024, Nikon Corporation, a Tokyo-based company, introduced the ECLIPSE Ti2-I Motorized Inverted Microscope, specifically designed for micro-insemination procedures such as ICSI (Intracytoplasmic Sperm Injection) and IMSI (Intracytoplasmic Morphologically-Selected Sperm Injection). This cutting-edge microscope improves the workflow in reproductive medicine, particularly in infertility treatment, by facilitating the performance of intricate procedures for specialists.
Leading companies in the infertility treatment market are innovating products, such as pre-filled pens, to minimize errors in the fertility treatment process. These pre-filled pens reduce mistakes by providing pre-measured doses, thereby enhancing precision and convenience. Oxolife, a Spain-based company focused on embryo implantation and ovulation restoration, has developed a first-in-class product candidate called OXO-001. This groundbreaking treatment aims to improve the embryo implantation process, potentially increasing success rates in fertility treatments. OXO-001 is specifically designed to meet the unique needs in reproductive medicine, offering a novel solution for patients facing difficulties with ovulation and embryo implantation. By addressing these critical aspects of fertility, Oxolife aims to provide a valuable option for individuals and couples looking to conceive.
In June 2024, CooperSurgical, a U.S.-based company focused on women's health, acquired ZyMōt Fertility for an undisclosed amount. This acquisition enables CooperSurgical to strengthen its presence in the fertility sector by integrating ZyMōt’s innovative solutions into its portfolio. ZyMōt Fertility is a U.S.-based company that specializes in advanced technologies aimed at supporting reproductive health.
Major companies operating in the infertility treatment market are The Cooper Companies Inc., Cook Group Incorporated, Vitrolife AB, Thermo Fisher Scientific Inc., Esco Micro Pte. Ltd., Genea Limited, IVFtech ApS, FUJIFILM Irvine Scientific Inc., The Baker Company Inc., Kitazato Corporation, Rocket Medical PLC, IHMedical A/S, Hamilton Thorne Ltd., Carl Zeiss AG, MedGyn Products Inc., DxNow Inc., Nidacon International AB, Gynotec B.V., SAR Healthline Pvt. Ltd., InVitroCare Inc., Boston IVF, Shady Grove Fertility LLC, CCRM Fertility Co. LLC, IVI-RMA Global, Fertility Centers of Illinois, New Hope Fertility Center, Pacific Fertility Center, Houston Fertility Institute, Sher Fertility Institute, Columbia Asia Fertility Centre, Bourn Hall Fertility Clinic, Manipal Fertility, Morpheus IVF, Nova IVF Fertility, Indira IVF, Bloom Fertility Centre, Cloudnine Fertility, Oasis Fertility, Apollo Fertility, Milann Fertility Center, Fakih IVF, Procrea Fertility, The Montreal Fertility Center, The Center for Reproductive Medicine, The Reproductive Medicine Group, The Fertility Institute.
North America was the largest region in the infertility treatment market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the infertility treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infertility treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Infertility treatment encompasses procedures designed to address reproductive challenges in both males and females. Infertility itself is characterized by the inability to achieve pregnancy following 12 months or more of regular, unprotected sexual activity. In females, factors such as endometriosis, uterine fibroids, or thyroid issues can contribute to this condition, while men experiencing fertility issues may present with low testosterone levels or diminished sperm counts.
The primary components constituting infertility treatment are equipment, media and consumables, and associated accessories. Equipment in this context refers to a wide range of tools, instruments, machinery, and materials employed for medical purposes in treating infertility in both genders. Various procedures, including assisted reproductive technology, artificial insemination, fertility-related surgeries, utilize a diverse array of drugs such as clomiphene citrate, letrozole, serophene, hormonal treatments, among others. Patients seeking infertility treatment typically fall into categories of female or male infertility, while end users of these treatments comprise hospitals, surgical clinics, cryobanks, and research institutes.
The infertility treatment market research report is one of a series of new reports that provides infertility treatment market statistics, including infertility treatment industry global market size, regional shares, competitors with an infertility treatment market share, detailed infertility treatment market segments, market trends and opportunities, and any further data you may need to thrive in the infertility treatment industry. This anomaly detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The infertility treatment market includes revenues earned by entities by providing fertility preservation, genetic carrier screening, egg treatment services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The infertility treatment market size is expected to see strong growth in the next few years. It will grow to $2.8 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to expanding access to fertility clinics, advances in reproductive medicine, innovations in gamete and embryo culture, advancements in male contraception, focus on oocyte quality improvement. Major trends in the forecast period include technological advancements in assisted reproductive technologies (art), increasing prevalence of infertility, expanding age of parenthood, fertility preservation services, nutritional and lifestyle interventions.
The decline in the global fertility rate is a significant factor driving the growth of the infertility treatment market. The fertility rate at a specific age is defined as the number of children born alive to women of that age during the year, expressed as a percentage of the average annual population of women of that age. Globally, the fertility rate has been steadily decreasing due to various factors, including the increasing trend of late marriages and rising age-related infertility. This reduction in fertility rates has resulted in a marked increase in the demand for infertility treatment products that help determine the fertility window for both males and females. For example, in June 2022, the World Economic Forum, a Switzerland-based international non-governmental organization, reported that fertility rates have declined worldwide over the past 70 years, with a total decrease of 50% recorded in 2022. Thus, the decline in the global fertility rate is driving the demand for infertility treatment products.
The increasing demand for surrogacy is anticipated to drive the growth of the infertility treatment market in the future. Surrogacy is a reproductive arrangement in which a woman, known as the surrogate, carries and gives birth to a child for another individual or couple, referred to as the intended parents. This option is often pursued in infertility treatment when a woman or couple cannot carry a pregnancy due to medical issues, repeated pregnancy loss, or other fertility challenges. For example, in December 2022, The Australian Broadcasting Corporation, an Australia-based radio broadcasting station, reported that approximately 100 Australian women give birth to babies for other families each year through surrogacy. Therefore, the rising demand for surrogacy is fueling the growth of the infertility treatment market.
Technological innovation is a significant trend gaining traction in the infertility treatment market. Leading companies in this sector are concentrating on developing new technological solutions to enhance their market position. In July 2024, Nikon Corporation, a Tokyo-based company, introduced the ECLIPSE Ti2-I Motorized Inverted Microscope, specifically designed for micro-insemination procedures such as ICSI (Intracytoplasmic Sperm Injection) and IMSI (Intracytoplasmic Morphologically-Selected Sperm Injection). This cutting-edge microscope improves the workflow in reproductive medicine, particularly in infertility treatment, by facilitating the performance of intricate procedures for specialists.
Leading companies in the infertility treatment market are innovating products, such as pre-filled pens, to minimize errors in the fertility treatment process. These pre-filled pens reduce mistakes by providing pre-measured doses, thereby enhancing precision and convenience. Oxolife, a Spain-based company focused on embryo implantation and ovulation restoration, has developed a first-in-class product candidate called OXO-001. This groundbreaking treatment aims to improve the embryo implantation process, potentially increasing success rates in fertility treatments. OXO-001 is specifically designed to meet the unique needs in reproductive medicine, offering a novel solution for patients facing difficulties with ovulation and embryo implantation. By addressing these critical aspects of fertility, Oxolife aims to provide a valuable option for individuals and couples looking to conceive.
In June 2024, CooperSurgical, a U.S.-based company focused on women's health, acquired ZyMōt Fertility for an undisclosed amount. This acquisition enables CooperSurgical to strengthen its presence in the fertility sector by integrating ZyMōt’s innovative solutions into its portfolio. ZyMōt Fertility is a U.S.-based company that specializes in advanced technologies aimed at supporting reproductive health.
Major companies operating in the infertility treatment market are The Cooper Companies Inc., Cook Group Incorporated, Vitrolife AB, Thermo Fisher Scientific Inc., Esco Micro Pte. Ltd., Genea Limited, IVFtech ApS, FUJIFILM Irvine Scientific Inc., The Baker Company Inc., Kitazato Corporation, Rocket Medical PLC, IHMedical A/S, Hamilton Thorne Ltd., Carl Zeiss AG, MedGyn Products Inc., DxNow Inc., Nidacon International AB, Gynotec B.V., SAR Healthline Pvt. Ltd., InVitroCare Inc., Boston IVF, Shady Grove Fertility LLC, CCRM Fertility Co. LLC, IVI-RMA Global, Fertility Centers of Illinois, New Hope Fertility Center, Pacific Fertility Center, Houston Fertility Institute, Sher Fertility Institute, Columbia Asia Fertility Centre, Bourn Hall Fertility Clinic, Manipal Fertility, Morpheus IVF, Nova IVF Fertility, Indira IVF, Bloom Fertility Centre, Cloudnine Fertility, Oasis Fertility, Apollo Fertility, Milann Fertility Center, Fakih IVF, Procrea Fertility, The Montreal Fertility Center, The Center for Reproductive Medicine, The Reproductive Medicine Group, The Fertility Institute.
North America was the largest region in the infertility treatment market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the infertility treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infertility treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Infertility treatment encompasses procedures designed to address reproductive challenges in both males and females. Infertility itself is characterized by the inability to achieve pregnancy following 12 months or more of regular, unprotected sexual activity. In females, factors such as endometriosis, uterine fibroids, or thyroid issues can contribute to this condition, while men experiencing fertility issues may present with low testosterone levels or diminished sperm counts.
The primary components constituting infertility treatment are equipment, media and consumables, and associated accessories. Equipment in this context refers to a wide range of tools, instruments, machinery, and materials employed for medical purposes in treating infertility in both genders. Various procedures, including assisted reproductive technology, artificial insemination, fertility-related surgeries, utilize a diverse array of drugs such as clomiphene citrate, letrozole, serophene, hormonal treatments, among others. Patients seeking infertility treatment typically fall into categories of female or male infertility, while end users of these treatments comprise hospitals, surgical clinics, cryobanks, and research institutes.
The infertility treatment market research report is one of a series of new reports that provides infertility treatment market statistics, including infertility treatment industry global market size, regional shares, competitors with an infertility treatment market share, detailed infertility treatment market segments, market trends and opportunities, and any further data you may need to thrive in the infertility treatment industry. This anomaly detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The infertility treatment market includes revenues earned by entities by providing fertility preservation, genetic carrier screening, egg treatment services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Infertility Treatment Market Characteristics3. Infertility Treatment Market Trends and Strategies4. Infertility Treatment Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Infertility Treatment Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Infertility Treatment Market34. Recent Developments in the Infertility Treatment Market
5. Global Infertility Treatment Growth Analysis and Strategic Analysis Framework
6. Infertility Treatment Market Segmentation
7. Infertility Treatment Market Regional and Country Analysis
8. Asia-Pacific Infertility Treatment Market
9. China Infertility Treatment Market
10. India Infertility Treatment Market
11. Japan Infertility Treatment Market
12. Australia Infertility Treatment Market
13. Indonesia Infertility Treatment Market
14. South Korea Infertility Treatment Market
15. Western Europe Infertility Treatment Market
16. UK Infertility Treatment Market
17. Germany Infertility Treatment Market
18. France Infertility Treatment Market
19. Italy Infertility Treatment Market
20. Spain Infertility Treatment Market
21. Eastern Europe Infertility Treatment Market
22. Russia Infertility Treatment Market
23. North America Infertility Treatment Market
24. USA Infertility Treatment Market
25. Canada Infertility Treatment Market
26. South America Infertility Treatment Market
27. Brazil Infertility Treatment Market
28. Middle East Infertility Treatment Market
29. Africa Infertility Treatment Market
30. Infertility Treatment Market Competitive Landscape and Company Profiles
31. Infertility Treatment Market Other Major and Innovative Companies
35. Infertility Treatment Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Infertility Treatment Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on infertility treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for infertility treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The infertility treatment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Product: Equipment; Media and Consumables; Accessories2) by Procedure: Assisted Reproductive Technology; Artificial Insemination; Fertility Surgeries; Other Infertility Treatment Procedures
3) by Drugs: Clomiphene Citrate; Letrozole; Serophene; Hormone Treatment; Other Drugs
4) by Patient Type: Female Infertility Treatment; Male Infertility Treatment
5) by End User: Hospitals and Surgical Clinics; Cryobanks; Research Institutes
Subsegments:
1) by Equipment: in Vitro Fertilization (IVF) Equipment; Cryopreservation Equipment; Sperm and Embryo Storage Systems; Ultrasound Machines2) by Media and Consumables: Culture Media; Sperm Processing Media; Embryo Transfer Media; Oocyte Preservation Media
3) by Accessories: Catheters; Needles and Syringes; Petri Dishes; Incubators
Key Companies Mentioned: the Cooper Companies Inc.; Cook Group Incorporated; Vitrolife AB; Thermo Fisher Scientific Inc.; Esco Micro Pte. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Infertility Treatment market report include:- The Cooper Companies Inc.
- Cook Group Incorporated
- Vitrolife AB
- Thermo Fisher Scientific Inc.
- Esco Micro Pte. Ltd.
- Genea Limited
- IVFtech ApS
- FUJIFILM Irvine Scientific Inc.
- The Baker Company Inc.
- Kitazato Corporation
- Rocket Medical PLC
- IHMedical A/S
- Hamilton Thorne Ltd.
- Carl Zeiss AG
- MedGyn Products Inc.
- DxNow Inc.
- Nidacon International AB
- Gynotec B.V.
- SAR Healthline Pvt. Ltd.
- InVitroCare Inc.
- Boston IVF
- Shady Grove Fertility LLC
- CCRM Fertility Co. LLC
- IVI-RMA Global
- Fertility Centers of Illinois
- New Hope Fertility Center
- Pacific Fertility Center
- Houston Fertility Institute
- Sher Fertility Institute
- Columbia Asia Fertility Centre
- Bourn Hall Fertility Clinic
- Manipal Fertility
- Morpheus IVF
- Nova IVF Fertility
- Indira IVF
- Bloom Fertility Centre
- Cloudnine Fertility
- Oasis Fertility
- Apollo Fertility
- Milann Fertility Center
- Fakih IVF
- Procrea Fertility
- The Montreal Fertility Center
- The Center for Reproductive Medicine
- The Reproductive Medicine Group
- The Fertility Institute
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 1.97 Billion |
| Forecasted Market Value ( USD | $ 2.8 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 47 |
